We are live on ! Find out more
RO

Robert Olstein Olstein Capital Management

AUM $458M
1-Year Est. Return 6.27%
 

Robert Olstein is the founder of Olstein Capital Management and a long-time advocate of forensic accounting and quality-of-earnings analysis in equity investing. His process looks beyond headline multiples to assess earnings sustainability and balance-sheet risk. Olstein’s work is frequently referenced by investors who prioritize accounting diligence.

This Fund
S&P 500
This Quarter Est. Return
+2.58%
1 Year Est. Return
+6.27%
3 Year Est. Return
+16.62%
5 Year Est. Return
+3.39%
10 Year Est. Return
+96.48%
AUM
$788M
AUM Growth
+$6.55M
Cap. Flow
-$9.33M
Cap. Flow %
-1.18%
Top 10 Hldgs %
19.28%
Holding
124
New
15
Increased
36
Reduced
41
Closed
9

Sector Composition

Rank Sector Weight
1 Industrials 20.25%
2 Technology 17.48%
3 Financials 17.08%
4 Consumer Discretionary 16.2%
5 Healthcare 13.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJM icon
76
J.M. Smucker
SJM
$13.3B
$5.17M 0.66%
43,700
+7,000
+19% +$885K
TRV icon
77
Travelers Companies
TRV
$75.8B
$5.06M 0.64%
40,000
-1,000
-2% -$123K
TFC icon
78
Truist Financial
TFC
$61.6B
$5.04M 0.64%
111,000
+15,000
+16% +$651K
TXN icon
79
Texas Instruments
TXN
$241B
$5.04M 0.64%
+65,500
New +$5.25M
INTC icon
80
Intel
INTC
$476B
$5.03M 0.64%
149,000
PG icon
81
Procter & Gamble
PG
$336B
$4.97M 0.63%
57,000
-3,000
-5% -$264K
BIG
82
DELISTED
Big Lots, Inc.
BIG
$4.72M 0.6%
97,710
PEP icon
83
PepsiCo
PEP
$196B
$4.39M 0.56%
38,000
IBM icon
84
IBM
IBM
$222B
$4.31M 0.55%
29,288
+7,322
+33% +$1.1M
HOLX
85
DELISTED
Hologic
HOLX
$4.15M 0.53%
91,500
-75,500
-45% -$3.33M
ADEA icon
86
Adeia
ADEA
$2.89B
$4.08M 0.52%
518,125
+214,440
+71% +$1.81M
TMO icon
87
Thermo Fisher Scientific
TMO
$233B
$4.01M 0.51%
+23,000
New +$3.86M
BAX icon
88
Baxter International
BAX
$13.6B
$4M 0.51%
+66,000
New +$3.75M
ISRG icon
89
Intuitive Surgical
ISRG
$134B
$3.93M 0.5%
37,800
-39,600
-51% -$3.81M
NKE icon
90
Nike
NKE
$60.5B
$3.89M 0.49%
66,000
XOM icon
91
ExxonMobil
XOM
$679B
$3.88M 0.49%
48,000
+2,000
+4% +$164K
GLW icon
92
Corning
GLW
$129B
$3.83M 0.49%
127,600
BWA icon
93
BorgWarner
BWA
$13.8B
$3.81M 0.48%
102,240
+3,408
+3% +$124K
CECO icon
94
Ceco Environmental
CECO
$4.19B
$3.62M 0.46%
394,750
+18,900
+5% +$191K
HLIT icon
95
Harmonic Inc
HLIT
$1.36B
$3.41M 0.43%
649,401
DIN icon
96
Dine Brands
DIN
$454M
$3.37M 0.43%
76,500
+27,540
+56% +$1.38M
NTUS
97
DELISTED
Natus Medical Inc
NTUS
$3.24M 0.41%
86,845
ATRO icon
98
Astronics
ATRO
$3.35B
$2.89M 0.37%
130,796
+10,496
+9% +$235K
FTD
99
DELISTED
FTD Companies, Inc. Common Stock
FTD
$2.88M 0.37%
143,950
-19,550
-12% -$377K
PBPB
100
DELISTED
Potbelly
PBPB
$2.8M 0.36%
243,540
-129,260
-35% -$1.58M

Similar funds

Robert Olstein's Q2 2017 Portfolio in Review

As of Q2 2017, Robert Olstein held 124 positions worth $788M, up 0.84% from $781M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Robert Olstein's Q2 2017 filing shows 15 new, 36 increased, 41 reduced and 9 closed positions. Its largest new stake was Western Digital: 114,440 shares worth $7.66M. The largest sale was Vitamin Shoppe Inc., an estimated $16.2M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • Robert Olstein's largest Q2 2017 buy was Western Digital: 114,440 shares worth $7.66M.
  • Robert Olstein added most to Alphabet (Google) Class C in Q2 2017, an estimated $11.4M increase.
  • Robert Olstein's biggest Q2 2017 reduction was Zebra Technologies, cutting an estimated $7.5M.
  • Robert Olstein fully exited Vitamin Shoppe Inc. in Q2 2017, selling an estimated $16.2M.
  • Robert Olstein's ten largest holdings make up 19% of its $788M portfolio in Q2 2017.
  • Robert Olstein opened 15 new positions and closed 9 in Q2 2017.
  • Robert Olstein's portfolio value rose 0.84% quarter-over-quarter to $788M.

Based on Olstein Capital Management's 13F filing for Q2 2017, filed 3 Aug 2017.